Measurement kit equipped with biosensor

The measurement kit with a biosensor and a pKa compound in the measuring container addresses the long waiting times of conventional biosensors, enabling rapid and accurate detection of substances in biological fluids and food/beverages.

WO2026239711A1PCT designated stage Publication Date: 2026-11-19KAO CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2026/006685
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-13
Filing Date
2026-02-24
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

Conventional biosensors equipped with enzyme electrodes face long waiting times before achieving stable electrical signal output for substance measurement in solutions, necessitating a need for rapid detection methods.

Method used

A measurement kit comprising a biosensor with an enzyme electrode and a measuring container containing a compound with a pKa of 8 or more and less than 12, which dissolves in the solution to be measured, allowing for rapid detection of substances by shortening the waiting time.

Benefits of technology

The kit enables rapid and sensitive detection of substances in biological fluids and food/beverages by reducing the biosensor's waiting time and enhancing measurement accuracy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2026006685_19112026_PF_FP_ABST
    Figure JP2026006685_19112026_PF_FP_ABST
Patent Text Reader

Abstract

This measurement kit comprises a biosensor that is provided with an enzyme electrode, and a measurement container that is for containing a solution to be measured, wherein the enzyme electrode includes an electroconductive layer and a reagent layer, the reagent layer contains an enzyme, the reagent layer is immobilized on the electroconductive layer, the measurement container contains a compound having a pKa of at least 8 and less than 12 at 25°C as calculated by a pH titration method, and when the compound is dissolved in the solution to be measured contained in the measurement container, the concentration of the compound in the solution to be measured exceeds 0.05 M.
Need to check novelty before this filing date? Find Prior Art

Description

Measurement kit equipped with a biosensor

[0001] The present invention relates to a measurement kit equipped with a biosensor for electrochemically analyzing a substance to be measured contained in a solution.

[0002] In recent years, there has been a growing need to selectively detect organic substances in bodily fluids such as sweat, saliva, urine, tears, and blood for monitoring bodily conditions or for diagnosing and preventing diseases. Among these methods, non-invasive measurements that do not involve procedures that harm the body, such as blood sampling, are attracting particular attention. Sweat and urine are useful as bodily fluids for measurement because they can be easily collected without harming the body. However, bodily fluids that can be measured non-invasively tend to have lower concentrations of organic substances than blood, thus requiring more sensitive sensors. Enzyme sensors, which utilize the high selectivity of enzymes to selectively and sensitively detect organic substances, are promising as such highly sensitive sensors.

[0003] Patent Document 1 discloses that an enzyme solution containing Tris-HCl buffer is dispensed into an electrode layer, dried, and the reagent solidifies on the electrode to form an enzyme electrode. Patent Documents 2 to 4 describe using a solution containing a target substance and Tris as the solution to be measured for a biosensor.

[0004] (Patent Document 1) Japanese Unexamined Patent Publication No. 2014-006155 (Patent Document 2) Japanese Unexamined Patent Publication No. 2011-149878 (Patent Document 3) Japanese Unexamined Patent Publication No. 2008-134255 (Patent Document 4) Japanese Unexamined Patent Publication No. 2005-069836

[0005] In one embodiment, the present invention provides a measurement kit comprising a biosensor equipped with an enzyme electrode and a measuring container for holding a solution to be measured, wherein the enzyme electrode comprises a conductive layer and a reagent layer, the reagent layer comprises an enzyme, the reagent layer is immobilized on the conductive layer, the measuring container contains a compound having a pKa of 8 or more and less than 12 at 25°C as calculated by pH titration, and when the compound is dissolved in the solution to be measured placed in the measuring container, the concentration of the compound in the solution to be measured exceeds 0.05 M.

[0006] In another embodiment, the present invention provides a system for measuring a substance, comprising: a measurement kit comprising the biosensor and a measuring container; a control unit for controlling the application of voltage to the biosensor; a detection unit for detecting a current value obtained by the application of voltage to the biosensor; a calculation unit for calculating the concentration of the substance to be measured in the solution to be measured from the current value; and an output unit for outputting the calculated concentration of the substance to be measured.

[0007] In another embodiment, the present invention provides a method for measuring a substance to be measured, comprising: supplying a solution to be measured to a measuring container of the measurement system; dissolving a compound in the solution to be measured, wherein the pKa at 25°C calculated by pH titration is 8 or more and less than 12, therein the concentration of the compound in the solution to be measured in which the compound is dissolved exceeds 0.05 M; contacting the electrode of a biosensor of the measurement system with the solution to be measured in which the compound is dissolved; applying a constant voltage to the biosensor with the control unit of the measurement system; detecting a current value obtained from the biosensor with the detection unit of the measurement system; and calculating the concentration of the substance to be measured in the solution to be measured with the calculation unit of the measurement system from the detected current value.

[0008] In another embodiment, the present invention provides an amino acid-related information provision service system for providing amino acid-related information about a test animal, the system comprising: a server; a user terminal; and a measuring device equipped with the aforementioned measurement kit, wherein the user terminal and the measuring device are each identified, the user terminal is associated with the measuring device, the measuring device measures data on the amino acid concentration of a urine sample taken from the test animal and transmits the measured data along with the timing data of the measurement to the server, the server creates amino acid concentration-related information about the test animal based on the data transmitted from the measuring device and transmits the information to the user terminal associated with the measuring device, the user terminal outputs the amino acid concentration-related information about the test animal transmitted from the server, and the amino acid-related information about the test animal includes information on the urinary amino acid concentration of the test animal, or information on the renal function of the test animal created based on the urinary amino acid concentration.

[0009] An embodiment of the measurement kit of the present invention. A: Plan view of the biosensor, B: Measurement container containing a compound having a pKa of 8 or more and less than 12. I-I end view of the biosensor shown in Figure 1A. Embodiment of the biosensor. A: Plan view of a three-electrode system, B: Plan view of a two-electrode system biosensor. Schematic diagram showing the usage of the measurement kit equipped with the biosensor shown in Figure 3A. The biosensor is immersed in the solution to be measured in the measurement container. Schematic diagram showing an embodiment of a measurement system including the measurement kit equipped with the biosensor shown in Figure 3A. An embodiment of an amino acid-related information provision service system. An example of the operation of server 100, user terminal 200, and measurement system 300 in the amino acid-related information provision service system. Schematic diagram of the biosensor of Example 1. A: Plan view, B: I-I end view of A. Relationship between the current value measured using the measurement kit of Example 1 and the D-amino acid concentration. pH change rate in pH titration of Tris solution. The arrow indicates the first minimum value from the start of the titration, where x (=8.6) corresponds to the pKa of Tris. The rate of pH change in the pH titration of the CHES solution. The arrow indicates the first minimum value from the start of the titration, where x (=10.2) corresponds to the pKa of CHES. The rate of pH change in the pH titration of the TAPS solution. The arrow indicates the first minimum value from the start of the titration, where x (=9.1) corresponds to the pKa of TAPS. The rate of pH change in the pH titration of the boric acid solution. The arrow indicates the first minimum value from the start of the titration, where x (=10.3) corresponds to the pKa of boric acid. The rate of pH change in the pH titration of the phosphoric acid solution. The arrow indicates the first minimum value from the start of the titration, where x (=6.8) corresponds to the pKa of phosphoric acid. Detailed description of the invention

[0010] Conventional biosensors equipped with enzyme electrodes have a problem in measuring substances in solution: the time it takes from contact between the electrode and the solution until the electrical signal output stabilizes and a steady potential is obtained, i.e., the waiting time of the biosensor is long. There is a need to shorten the waiting time of the biosensor and to detect substances rapidly.

[0011] According to the present invention, the waiting time of the biosensor can be shortened, and the substance to be measured can be detected rapidly. The measurement kit of the present invention can be used for measuring substances in biological fluids, or for measuring umami components and functional components in food and beverages, etc.

[0012] (1. Measurement kit equipped with a biosensor) The present invention provides a measurement kit equipped with a biosensor. The measurement kit of the present invention is used to measure the concentration of a substance to be measured in a solution that may contain the substance to be measured (hereinafter also referred to as the "solution to be measured"). The measurement kit of the present invention reduces the waiting time of the biosensor and enables rapid detection of the substance to be measured.

[0013] The measurement kit of the present invention comprises a biosensor and a measurement container for holding the solution to be measured. The biosensor of the measurement kit of the present invention is an enzyme sensor equipped with an enzyme electrode. The enzyme electrode includes a conductive layer and a reagent layer. The reagent layer contains an enzyme and is immobilized on the conductive layer. The measurement container of the measurement kit of the present invention contains a compound having a pKa of 8 or more and less than 12. When the solution to be measured is placed in the measurement container, the compound in the measurement container dissolves in the solution to be measured.

[0014] The solutions to be measured using the measurement kit of the present invention are not particularly limited, but examples include biological fluids such as sweat, saliva, urine, tears, and blood, or sample solutions derived therefrom, beverages and foods, or their dilutions or suspensions.

[0015] The substances to be measured by the measurement kit of the present invention are not particularly limited, but examples include biologically derived substances such as glucose, lactic acid, fructose, urea, uric acid, amino acids, bilirubin, cholesterol, alcohol, creatinine, and ascorbic acid.

[0016] In one embodiment, the substance to be measured is an amino acid, preferably a D-amino acid. Examples of D-amino acids include D-alanine, D-serine, D-arginine, D-lysine, D-asparagine, D-histidine, D-ornithine, D-glutamine, D-threonine, D-tyrosine, D-valine, D-phenylalanine, D-methionine, D-glutamic acid, D-aspartic acid, D-leucine, D-tryptophan, D-cysteine, D-isoleucine, and D-proline, which are D-type free amino acids. One or more selected from the above D-amino acids can be detected as the substance to be measured.

[0017] In one embodiment, the solution to be measured is a urine sample collected from a test animal. The urine sample can be one used in general urine tests, such as urine collected directly from excreted urine, or urine collected from or held in a pet toilet or diaper. The urine sample may be fresh urine, stored urine, concentrated urine, or a diluted version thereof. The test animal may be a mammal, including humans and non-human animals, preferably a non-human animal, and more preferably a feline.

[0018] The configuration of the measurement kit of the present invention will be described below with reference to the drawings. However, the illustrated measurement kit, its biosensor, and measurement container are exemplary embodiments of the present invention and do not limit the scope of the present invention. For example, the shapes and relative positions of electrodes such as the enzyme electrode 2, counter electrode 3, and reference electrode 4 in the biosensor, as well as other parts, and the shape of the measurement container are not limited to those shown.

[0019] Figure 1 shows one embodiment of the measurement kit of the present invention. Figure 1A is a plan view of the biosensor, and Figure 1B shows a measurement container containing a compound (compound 8 in the figure) having a pKa of 8 or more and less than 12.

[0020] In Figure 1A, the biosensor 1 comprises an enzyme electrode 2, which includes a conductive layer and a reagent layer, disposed on a substrate 5. Figure 2 is an I-I end view of the biosensor shown in Figure 1A. As shown in Figure 2, the enzyme electrode 2 includes a conductive layer 2a and a reagent layer 2b that is laminated and immobilized on the conductive layer 2a. The reagent layer 2b shown in Figure 2 is disposed on the conductive layer 2a so as to cover a portion of the surface of the conductive layer 2a.

[0021] Examples of materials for the conductive layer 2a include metals such as gold, palladium, platinum, rhodium, indium, and iridium, and conductive carbon materials. Preferred examples include conductive carbon materials, platinum, and gold. Conductive materials that do not react with the solution containing the substance to be measured are preferred. These conductive materials can be used individually or in combination of two or more, but conductive carbon materials are preferably used.

[0022] From the viewpoint of promoting electron transfer, the enzyme electrode 2 preferably contains a mediator (electron transfer promoter). The mediator is not particularly limited as long as it is a redox substance that can transfer electrons to the electrode, and conventionally known reversibly redox compounds can be used. Preferably, the mediator is water-insoluble (i.e., its solubility in water at 25°C is 1 g / 100 mL or less). Examples of the mediator include metal complexes and their derivatives such as Prussian blue, ferrocene and its derivatives, osmium complexes and its derivatives (monomers, polymers), ruthenium complexes; quinones, dichloroindophenol, tetrathiafulvalene (TTF) and its derivatives; and tetracyanoquinodimethane. Any one of these mediators can be used alone or in combination of two or more, but Prussian blue is preferred. The reduced form of Prussian blue reacts with hydrogen peroxide produced by the reaction between the enzyme and the substance being measured to become the oxidized form of Prussian blue. This oxidized form accepts electrons from the conductive layer and returns to the reduced form, so that an electric current is generated via Prussian blue in accordance with the reaction between the enzyme and the substance being measured.

[0023] The mediator may be contained in the conductive layer 2a or the reagent layer 2b, but is preferably contained only in the conductive layer 2a. Preferably, a layer of the mediator-containing conductive layer 2a' is formed so as to cover a part of the surface of the conductive layer 2a, and the reagent layer 2b is immobilized thereon (see FIG. 8B). The mediator-containing conductive layer 2a' is a layer of a mixture of a conductive material and a mediator. For example, the conductive layer 2a' can be obtained by forming a layer on a part of the surface of the conductive layer 2a using a conductive material containing a mediator (e.g., carbon kneaded with a mediator, preferably Prussian blue-containing carbon paste).

[0024] The content of the mediator in the enzyme electrode 2 is, when the total amount of the conductive material and the mediator contained in the mediator-containing portion of the enzyme electrode 2 (e.g., the conductive layer 2a') is taken as 100% by mass, preferably 0.01% by mass or more, more preferably 0.05% by mass or more, still more preferably 0.10% by mass or more, and even more preferably 0.50% by mass or more from the viewpoint of promoting electron transfer, and is preferably 10% by mass or less, more preferably 7.5% by mass or less, still more preferably 5.0% by mass or less from the viewpoint of suppressing the occurrence of noise during electrochemical measurement due to excessive electron transfer.

[0025] Preferably, the conductive layer 2a contains the mediator. The content of the mediator in the conductive layer 2a is, from the viewpoint of promoting electron transfer, preferably 0.01% by mass or more, more preferably 0.05% by mass or more, still more preferably 0.10% by mass or more, even more preferably 0.50% by mass or more, and from the viewpoint of suppressing the occurrence of noise during electrochemical measurement due to excessive electron transfer, is preferably 10% by mass or less, more preferably 7.5% by mass or less, still more preferably 5.0% by mass or less.

[0026] When the conductive layer 2a contains the mediator, the content of the conductive material in the conductive layer 2a is, from the viewpoint of promoting electron transfer, preferably 90.0 mass% or more, more preferably 92.5 mass% or more, still more preferably 95.0 mass% or more, and from the viewpoint of suppressing the occurrence of noise during electrochemical measurement due to excessive electron transfer, it is preferably 99.99 mass% or less, more preferably 99.95 mass% or less, still more preferably 99.90 mass% or less, and even more preferably 99.50 mass% or less.

[0027] The content of the mediator in the reagent layer 2b is preferably 0.1 μg / mm 2 or less, more preferably 0.01 μg / mm 2 or less, and still more preferably, the reagent layer 2b does not contain the mediator.

[0028] The area of the reagent layer 2b in contact with the conductive layer 2a is not particularly limited, but from the viewpoint of forming the reagent layer 2b with a sufficient enzyme amount, it is preferably 0.1 mm 2 or more, and from the viewpoint of downsizing the biosensor, it is preferably 1000 mm 2 or less. The thickness of the enzyme electrode 2 is not particularly limited, but is preferably 10 nm or more and 100 μm or less.

[0029] The enzyme contained in the reagent layer 2b may be an enzyme that can directly exchange electrons with the conductive layer 2a through reaction with the analyte, or any enzyme that can exchange electrons with the conductive layer 2a via the product of the reaction with the analyte. Examples of the enzyme include glucose oxidase (GOD), glucose dehydrogenase (GDH), lactate oxidase, lactate dehydrogenase, fructose dehydrogenase, invertase, amylase, urease, uricase, amino acid oxidase, bilirubin oxidase, cholesterol oxidase, alcohol oxidase, alcohol dehydrogenase, creatininase and the like. However, the type of enzyme used is not particularly limited and can be appropriately selected according to the analyte.

[0030] In one embodiment, the enzyme is an amino acid oxidase, preferably at least one of D-amino acid oxidase and L-amino acid oxidase, more preferably D-amino acid oxidase. The amino acid in the test solution is decomposed into hydrogen peroxide, keto acid and ammonia by reacting with the amino acid oxidase. Hydrogen peroxide undergoes the reaction H₂O₂ → 2H in the conductive layer 2a + +O₂+2e - and is thus converted into an electric current.

[0031] The content of the enzyme in the reagent layer 2b is preferably 0.1 μg / mm, from the viewpoint of sufficiently ensuring the oxidation-reduction reaction required for quantifying the target analyte 2 or more, more preferably 0.2 μg / mm 2 or more, even more preferably 0.5 μg / mm 2 or more, while from the viewpoint of suppressing inhibition of the enzymatic reaction caused by the enzyme itself acting as electrical resistance, the content is preferably 30 μg / mm 2 or less, more preferably 25 μg / mm 2 or less, even more preferably 15 μg / mm 2 or less. As used herein, the amount of enzyme in the reagent layer 2b as described above refers to the amount of enzyme per 1 mm of the region in the reagent layer 2b that can come into contact with the test solution 2 .

[0032] The reagent layer 2b and the enzyme contained therein are immobilized on the conductive layer 2a. Thereby, when the enzyme electrode 2 is immersed in the test solution, the enzyme in the reagent layer 2b is retained on the conductive layer 2a, and a measurable electric current can be generated in the enzyme electrode 2 by the reaction between the enzyme and the target analyte. As described above, the reagent layer 2b may be directly immobilized on the conductive layer 2a, or may be immobilized on the mediator-containing conductive layer 2a'.

[0033] The reagent layer 2b can be immobilized on the conductive layer 2a by mixing the enzyme and an enzyme immobilization agent and applying it to the conductive layer 2a, or by crosslinking the enzyme applied to the conductive layer 2a with a crosslinking agent. By immobilizing the enzyme on the conductive layer 2a using such an enzyme immobilization agent or by crosslinking, the elution of the enzyme into the solution to be measured can be inhibited, and the decrease in the reaction efficiency of the reagent layer caused by enzyme elution can be suppressed. As the enzyme immobilization agent, a polymer enzyme immobilization agent capable of inhibiting enzyme elution is preferred. Preferably, the reagent layer 2b contains a polymer enzyme immobilization agent in addition to the enzyme. Examples of such polymer enzyme immobilization agents include hydrogels, cured polymers, and crosslinked polymers. Of these, cured polymers are preferred.

[0034] Examples of the hydrogels include hydrogels of compounds such as chitosan, chitosan methacrylate, glycol chitosan, glycol chitosan methacrylate, alginic acid, alginic acid methacrylate, hyaluronic acid (HA), and HA methacrylate, as well as their salts. Any one of these can be used alone or in combination of two or more. For example, a reagent layer 2b containing an enzyme and a hydrogel can be formed by dropping an aqueous solution containing an enzyme and a hydrogel onto a conductive layer 2a on a substrate 5 and drying it.

[0035] Examples of the curable polymer and crosslinked polymer include photosensitive polymers (for example, water-soluble photosensitive resins in which photosensitive groups are directly bonded to a water-soluble polymer), organic molecules having crosslinkable reactive groups, and curable polymers or crosslinked polymers formed from water-soluble polymers. Preferably, a photosensitive polymer is used. For example, an aqueous solution containing an enzyme and a photosensitive polymer can be dropped onto a conductive layer 2a on a substrate 5, and cured by light (UV, etc.) irradiation to form a reagent layer 2b containing a cured product of the enzyme and photosensitive polymer. From the viewpoint of forming a curable polymer with sufficient strength to suppress the elution of the enzyme by light irradiation, it is preferable that the photosensitive polymer has an azide group. Furthermore, since the polymer structure of the photosensitive polymer needs to be stable and not decompose during the preparation of the aqueous solution and its light irradiation, it is preferable that the photosensitive polymer has a highly stable amide bond. An example of a preferred photosensitive polymer is Biosurfine® AWP-MRH (manufactured by Toyo Gosei Kogyo Co., Ltd.).

[0036] From the viewpoint of effectively retaining the enzyme in the reagent layer 2b, the content of the polymer enzyme immobilization agent is preferably 0.1 μg / mm³. 2 More preferably 0.2 μg / mm 2 More preferably 0.5 μg / mm 2 Therefore, from the viewpoint of suppressing the inhibition of the enzymatic reaction by the enzyme immobilizer, 50 μg / mm³ is preferred. 2 More preferably, 40 μg / mm² 2 More preferably, 30 μg / mm² 2 The following applies: In this specification, the amount of polymer enzyme immobilizer in the reagent layer 2b as described above refers to the 1 mm area of ​​the reagent layer 2b that is in contact with the solution to be measured. 2 This refers to the amount of the enzyme immobilizing agent per unit.

[0037] In the reagent layer 2b, the mass ratio of the enzyme to the polymer enzyme immobilizer (enzyme / polymer enzyme immobilizer) is preferably 0.01 or higher, more preferably 0.05 or higher, and even more preferably 0.10 or higher, from the viewpoint of suppressing inhibition of the enzymatic reaction by the enzyme immobilizer, and preferably 10 or lower, more preferably 7.5 or lower, and even more preferably 5 or lower, from the viewpoint of good retention of the enzyme in the reagent layer.

[0038] The reagent layer 2b may further contain stabilizers, other polymers, surfactants, and other reagents that are advantageous for measuring the concentration of the substance to be measured.

[0039] The measuring container 7 contains a compound having a pKa of 8 or more and less than 12. pKa represents the acid dissociation constant. In this specification, the pKa of a compound means the acid dissociation constant of the compound at 25°C, calculated by pH titration. Measurement of pKa by pH titration can be performed using a commercially available titrator (for example, a potentiometric automatic titrator AT-710; manufactured by Kyoto Electronics Manufacturing Co., Ltd.).

[0040] More specifically, the pKa of a compound may refer to the pKa of the compound at 25°C in an ultrapure aqueous solution containing 0.1 mol / L of the compound. In a specific example of a method for measuring pKa, the following steps are taken: - Dissolve the target compound in ultrapure water to a concentration of 0.1 mol / L; - Adjust the pH of the resulting solution to 3 or less using hydrochloric acid of an arbitrary concentration under conditions of proper stirring; - Titrate the solution with 0.1 mol / L sodium hydroxide until the pH reaches 12 or higher, where the amount of sodium hydroxide added at one time is 0.05 to 0.2 mL; - Create a graph of the pH change rate, where y is the pH change rate per titration (pH / mL) and x is pH, and apply a smoothing treatment to the graph; - Define the value of x at which, when x is 3 or greater and 12 or less, the absolute value of y first becomes a minimum after decreasing to 0.3 or less (i.e., the pH change is minimum, and consequently the buffering capacity is maximum), as pKa. For reference, Figure 10 shows a graph of the pH change rate for Tris. The arrow in the figure indicates the first local minimum, and x (=8.6) at that time corresponds to pKa.

[0041] Preferred examples of compounds having a pKa of 8 or more and less than 12 include compounds having an amine moiety, boric acid, and boronic acid. Of these, compounds having an amine moiety are preferred. Examples of compounds having an amine moiety include trishydroxymethylaminomethane (Tris), 2-cyclohexylaminoethanesulfonic acid (CHES), N-tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid (TAPS), and N,N-di(2-hydroxyethyl)glycine. Of these, Tris is preferred. Any one of the compounds listed above can be used alone or in combination of two or more.

[0042] The measuring container 7 may contain, in addition to the compound with a pKa of 8 or more and less than 12, other substances that are advantageous for measuring the concentration of the substance to be measured. For example, the measuring container 7 may further contain a pH adjusting agent. The pH adjusting agent adjusts the pH of the solution to be measured, in which the compound with a pKa of 8 or more and less than 12 is dissolved, to a range in which the compound can buffer. By adjusting the pH of the solution to be measured to a range in which the compound can buffer, the reaction of the enzyme contained in the enzyme electrode is stabilized, enabling highly accurate measurement of the concentration of the substance to be measured.

[0043] Examples of pH adjusters, though not particularly limited, include acids such as inorganic acids (hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid), carboxylic acids, and sulfonic acids, as well as bases such as ammonia, primary amines, secondary amines, tertiary amines, and inorganic bases (alkali metals, alkaline earth metal hydroxides, alkali metals, alkaline earth metal carbonates).

[0044] The compound contained in the measuring container 7 may be in solid or liquid form, as long as it is soluble in the solution to be measured placed in the measuring container 7. For example, the measuring container 7 may contain the compound in powder form, or the compound may be immobilized on the inner wall of the measuring container 7. Alternatively, the measuring container 7 may contain a solution of the compound. In one example, the measuring container 7 containing the compound can be prepared by dropping a buffer solution prepared by mixing the compound with a pH adjuster into the measuring container 7 and drying it. In another example, the measuring container 7 may contain a buffer solution prepared by mixing the compound with a pH adjuster. Examples of such buffer solutions include Tris hydrochloride aqueous solution, CHES ammonium salt aqueous solution, TAPS ammonium salt aqueous solution, and ammonium borate aqueous solution. Therefore, the measuring container 7 may contain Tris hydrochloride, CHES ammonium salt, TAPS ammonium salt, or ammonium borate.

[0045] The amount of the compound contained in the measuring container 7 can be appropriately adjusted according to the amount of the solution to be measured placed in the measuring container 7. Preferably, the amount of the compound contained in the measuring container 7 is adjusted so that when the compound is dissolved in the solution to be measured placed in the measuring container 7, the concentration of the compound in the solution to be measured is greater than 0.05 M, more preferably 0.1 M or more, and even more preferably 0.1 to 2.0 M. If the amount of the compound contained in the measuring container 7 is small and the concentration of the compound in the solution to be measured is insufficient, the waiting time of the biosensor will not be sufficiently shortened.

[0046] The amount of the solution to be measured placed in the measuring container 7 can be set according to the size of the biosensor, etc. From the viewpoint of ease of operation when adding the solution to be measured to the measuring container 7, 0.1 to 1.0 mL is preferred. The shape and capacity of the measuring container 7 can be appropriately selected according to the size of the biosensor, the amount of the solution to be measured, etc., and are not particularly limited. The material of the measuring container 7 can be any material that does not react with the solution containing the substance to be measured. An example of the measuring container 7 is a microtube, etc.

[0047] The measurement kit of the present invention may be provided with the biosensor 1 pre-fixed inside the measurement container 7. Alternatively, in the measurement kit of the present invention, the substrate 5 of the biosensor 1 may be the wall of the measurement container 7, in which case the biosensor 1 is arranged so that its electrodes are exposed inside the measurement container 7. Alternatively, the measurement kit of the present invention may be provided with multiple measurement containers 7 for one biosensor 1, and the biosensor 1 may be used repeatedly.

[0048] In the measurement kit of the present invention, the biosensor may comprise a three-electrode system including an enzyme electrode, a counter electrode, and a reference electrode. Alternatively, the electrode system of the biosensor may be a two-electrode system including an enzyme electrode and a counter electrode. When the biosensor is brought into contact with the solution to be measured, the substance to be measured undergoes an electrochemical reaction at the enzyme electrode, causing changes in the electrical state of the enzyme electrode, such as the potential of the enzyme electrode relative to the reference electrode and the current flowing when the enzyme electrode and the counter electrode are electrically connected. In a two-electrode system, the counter electrode also functions as the reference electrode. Since the reference electrode potential changes when current flows through the reference electrode, a three-electrode system is preferable from the viewpoint of high-precision measurement.

[0049] Figure 3A shows one embodiment of a biosensor comprising a three-electrode system including an enzyme electrode 2, a counter electrode 3, and a reference electrode 4. Figure 3B shows one embodiment of a biosensor comprising a two-electrode system including an enzyme electrode 2 and a reference electrode 4. The enzyme electrode 2 is an electrode that transfers electrons with the substance to be measured, the counter electrode 3 is an electrode for conducting current with the enzyme electrode 2, and the reference electrode 4 is an electrode that serves as a reference for the potential of the enzyme electrode 2.

[0050] In Figures 3A and 3B, the counter electrode 3 and the reference electrode 4 are each composed of a conductive layer formed on the substrate 5, similar to the enzyme electrode 2. The electrodes of the electrode system are arranged so that they do not electrically contact each other. There are no particular restrictions on the distance between the enzyme electrode 2 and the counter electrode 3 and the reference electrode 4, but each is preferably 0.1 mm to 100 mm. There are no particular restrictions on the thickness of each electrode, but each is preferably 10 nm to 100 μm. There are no particular restrictions on the width of the counter electrode 3 and the reference electrode 4, but from the viewpoint of ensuring output stability of the biosensor and achieving miniaturization, they are preferably 0.1 to 100 mm.

[0051] The substrate 5 is made of an insulating material so that each electrode is not electrically connected. There are no particular restrictions on the insulating material, and it may be the same as that of an insulating substrate that constitutes a known electrochemical biosensor. Examples of the insulating material include films, paper, mica, ceramics, etc., made from materials such as polyimide, polystyrene, polycarbonate, polyvinyl chloride resin, and polyester such as polyethylene terephthalate (PET). Any one of these insulating materials can be used alone or in combination of two or more. There are no particular restrictions on the thickness of the substrate 5, but it is preferably 25 to 1000 μm.

[0052] The conductive layers of each electrode, namely the conductive layer 2a of the enzyme electrode 2, the counter electrode 3, and the reference electrode 4, can be formed on the surface of the substrate 5 by conventionally known methods such as screen printing, vacuum deposition, electron beam irradiation, sputtering, plating, CVD, ion plating coating, and inkjet printing, depending on the material. The material for the counter electrode 3 can be the same as the conductive layer 2a mentioned above. For example, the reference electrode 4 can be a silver / silver chloride electrode. For example, a silver / silver chloride electrode can be formed by printing a conductive material on the surface of the substrate 5 and then printing a silver / silver chloride paste on top of it. The mediator-containing conductive layer 2a' can be formed on the surface of the conductive layer 2a by conventionally known methods such as screen printing, vacuum deposition, electron beam irradiation, sputtering, plating, CVD, ion plating coating, and inkjet printing. Similarly, the reagent layer 2b can be formed on the surface of the conductive layer 2a or the mediator-containing conductive layer 2a'.

[0053] Alternatively, the counter electrode 3 or the reference electrode 4 may not be formed on the substrate 5, but may be configured as independent electrodes. For example, the counter electrode 3 may be formed from a metal wire, a metal plate, or the like. For example, the reference electrode 4 may be a glass tube in which a reference electrode material such as silver / silver chloride is sealed.

[0054] A portion of the electrode system on the substrate 5 may be covered with an insulating layer 6. For example, the insulating layer 6 covers the entire substrate 5 except for an opening 6a, through which the entire area of ​​the reagent layer 2b of the enzyme electrode 2, as well as a portion of the counter electrode 3 and the reference electrode 4, are exposed. Examples of materials for forming the insulating layer 6 include silicon oxide, silicon nitride, aluminum oxide, and photoresist that is transparent to visible light. Any one of these can be used alone or in combination of two or more. The insulating layer 6 can be formed by conventionally known methods such as screen printing, vacuum deposition, electron beam, sputtering, plating, CVD, ion plating coating, and inkjet. The thickness of the insulating layer 6 is preferably 10 nm to 100 μm.

[0055] In one embodiment, as shown in Figure 3A, the reagent layer 2b region of the enzyme electrode 2 is positioned at the end of the substrate 5, and the counter electrode 3 and reference electrode 4 are positioned next to it. When the solution to be measured is placed in the measuring container 7 containing the compound whose pKa is 8 or more and less than 12, the compound in the measuring container 7 dissolves in the solution to be measured. When the biosensor is immersed in the solution to be measured in the measuring container 7 containing the compound, from the side of the reagent layer 2b region (upper side in the figure), the electrode comes into contact with the solution to be measured and measurement of the substance to be measured begins.

[0056] (2. Measurement System) The measurement kit of the present invention is used to measure the concentration of a substance to be measured in a solution to be measured. The measurement system for measuring the concentration of a substance to be measured using the measurement kit of the present invention (hereinafter also referred to as "the measurement system of the present invention") will be described below.

[0057] As an exemplary embodiment of the measurement system of the present invention, a measurement system for chronoamperometry (CA) measurement using a measurement kit including the biosensor 1 shown in Figure 3A will be described with reference to Figures 4 and 5. Figure 4 is a schematic diagram showing the biosensor 1 connected to a potentiostat with the solution to be measured applied. Wiring from each electrode of the biosensor 1 is connected to the potentiostat 10, and the enzyme electrode 2, counter electrode 3, and reference electrode 4 are immersed in the solution to be measured 11 in the measurement container 7. The compound in the measurement container 7 with a pKa of 8 or more and less than 12 is dissolved in the solution to be measured 11. In chronoamperometry (CA) measurement, a constant potential is applied to the enzyme electrode 2 by the potentiostat 10, and the current value flowing through the enzyme electrode 2 is measured.

[0058] Figure 5 is a schematic diagram showing one embodiment of a measurement system using the measurement kit of the present invention. In the measurement system shown in Figure 5, a measurement device 20 is connected to a biosensor 1. The measurement device 20 includes a control unit 21 connected to the biosensor 1 and controlling the voltage application to the biosensor 1, a detection unit 22 that detects the current obtained by the voltage application to the biosensor 1, a calculation unit 23 that calculates the concentration of the substance to be measured in the solution 11 to be measured from the current value, and an output unit 24 that outputs the calculated concentration of the substance to be measured.

[0059] The control unit 21 is electrically connected to the biosensor 1 and controls the applied voltage value and voltage application time. The detection unit 22 measures the current generated due to the enzymatic reaction of the enzyme electrode 2 and sends the measurement result to the calculation unit 23. The control unit 21 and the detection unit 22 may be potentiostats equipped with the above functions. The calculation unit 23 calculates the concentration of the substance to be measured in the solution 11 from the current value sent from the detection unit 22. For example, the calculation unit 23 may be an information processing terminal including a memory that stores a linear function between the concentration of the substance to be measured and the current value, and a central processing unit (CPU) that includes a calculation unit for calculating the absolute value of the concentration of the substance to be measured. The output unit 24 may be included in the same information processing terminal as the calculation unit 23.

[0060] In one embodiment, the measurement system of the present invention further includes a display unit 25 that displays the concentration of the substance to be measured output from the output unit 24. The output unit 24 transmits the calculation result of the concentration of the substance to be measured by the calculation unit 23 to the display unit 25. The measurement system shown in Figure 5 includes the display unit 25. The display by the display unit 25 may be a digital display or an analog display. In another embodiment, the measurement system of the present invention includes a storage unit 26, and the calculation result of the concentration of the substance to be measured output from the output unit 24 is stored in the storage unit 26.

[0061] The connections between the detection unit 22 and the calculation unit 23, the calculation unit 23 and the output unit 24, and the output unit 24 and the display unit 25 or storage unit 26 may be wired or wireless. Examples of wireless connection interfaces include technologies such as Wi-Fi and Bluetooth (registered trademark).

[0062] (3. Amino Acid-Related Information Provision Service System) As an example of an application of the measurement kit of the present invention, an amino acid-related information provision service system (hereinafter also referred to as "the service system of the present invention") will be described. The service system of the present invention measures the amino acid concentration in a urine sample (solution to be measured) collected from a test animal and provides amino acid-related information concerning the test animal to the user of the service system.

[0063] The amino acid-related information concerning test animals provided by the service system of the present invention includes the urinary amino acid concentration of the test animal and information on the renal function of the test animal created based on the urinary amino acid concentration. The information on renal function includes the degree of renal function in the test animal, information for preventing renal disease corresponding to the degree of renal function (including information on diet and lifestyle habits that are effective for prevention), information on the risk and possibility of renal disease, as well as information on the presence or severity of renal disease and information on the treatment of renal disease (including information on treatment methods, drugs, doctors, hospital locations, etc.).

[0064] A user of the service system of the present invention is a person who wishes to receive amino acid-related information concerning the test animal. Examples of such users include, if the test animal is a non-human animal, a person who raises or manages the test animal, such as the owner of the test animal, a veterinarian, or an employee of an animal breeding facility such as a zoo (animal caretaker, veterinarian, facility manager). Alternatively, if the test animal is a human, the user may be the test subject themselves, or a family member or caregiver of the test subject may be the user.

[0065] In a typical embodiment, the service system of the present invention comprises a server, a user terminal, and a measuring device. Each user registered with the service system of the present invention uses at least one user terminal and at least one measuring device.

[0066] Each user terminal and each measuring device is identified. For example, each user terminal and each measuring device can be managed by assigning an ID number. Registered users can also be identified and managed by an ID number, etc. Each user terminal and each measuring device is associated with one of the registered users. In addition, each user terminal is associated with one or more of the measuring devices. The association between user terminals, measuring devices, and users can be performed and managed by their identification information (e.g., ID numbers).

[0067] A user may use one measurement device and one user terminal. Alternatively, a user may use multiple measurement devices, each associated with one or more user terminals. The number of users (or user terminals and measurement devices) that the service system may allow is not particularly limited and can be changed depending on, for example, the server's performance.

[0068] The aforementioned measuring device comprises the measuring kit of the present invention and can measure data on the amino acid concentration of a urine sample collected from a test animal. The measuring device is also configured to transmit the measured data to the server. Therefore, the measuring device may include a communication unit for transmitting the data.

[0069] The server creates amino acid-related information about the test animal based on the data transmitted from the measurement device and transmits this information to the user terminal associated with the measurement device. The user terminal outputs the amino acid concentration-related information about the test animal transmitted from the server.

[0070] Figure 6 shows one embodiment of the configuration of the service system of the present invention. The system shown in Figure 6 includes a server 100, user terminals 200, and a measuring device 300 including the measuring kit of the present invention. The server 100 is connected to a plurality of user terminals 200 and a plurality of measuring devices 300, and can send and receive data in a timely manner. In Figure 6, this connection is via the Internet 50, but is not limited to this.

[0071] Figure 6 shows multiple users A, B, and C who utilize the service system of the present invention. In the embodiment shown in Figure 6, users A, B, and C each own a test animal (e.g., a cat). In another embodiment, if the test animal is a human, users A, B, and C may be the test subject, or family members or caregivers of the test subject. Users A, B, and C each possess a user terminal (200A, 200B, and 200C in the figure) and a measurement device (300A, 300B, and 300C in the figure), which are each connected to the server 100.

[0072] Server 100 is an information processing device managed by the service operator. Server 100 receives data measured by the measurement device 300, creates amino acid-related information about the test animal, such as urinary amino acid concentration and information on renal function, from the received data, and transmits it to the user terminal 200.

[0073] The server 100 may include a communication interface for sending and receiving data with a user terminal 200 or a measuring device 300, a calculation unit for creating amino acid-related information about the test animal, such as urinary amino acid concentration and information on renal function, from data received from the measuring device 300, and a control unit for controlling the operation of the communication interface and the calculation unit.

[0074] Furthermore, the server 100 may include a storage unit for storing information necessary for calculations performed by the calculation unit, or for storing the calculation results. Alternatively, the storage unit may be installed outside the server 100. The storage unit may store various applications for executing the amino acid-related information provision service system according to the present invention, amino acid-related information about test animals created by the server 100, and various databases used to create the amino acid-related information. Examples of such databases, though not limited to them, include a user information database that stores attribute information about users, test animals, and measurement devices owned by each user; a renal function information database that stores information on the association between amino acid concentration and renal function, and information on the preservation of renal function or the prevention or treatment of renal diseases; and an amino acid-related information database that stores amino acid-related information about test animals for each user. These databases can be referenced from each other as needed when the server 100 creates amino acid-related information.

[0075] In the embodiment shown in Figure 6, only one server 100 is shown, but the server 100 may be composed of multiple information processing devices, and the processing performed by the server 100 may be distributed and executed by the multiple information processing devices.

[0076] The user terminals 200 (200A, 200B, 200C, etc.) receive and output amino acid-related information concerning the test animals from the server 100. The format of the output is not particularly limited and may include screen display, printing, or recording in a database. In a preferred embodiment, the user terminal 200 has an application program (hereinafter also referred to as "app") corresponding to the amino acid-related information provision service system of the present invention installed, and the user terminal 200 may output the amino acid-related information provided from the server 100 via the app. As the user terminal 200, for example, an information processing terminal such as a smartphone, mobile phone, tablet PC (Personal Computer), notebook PC, or desktop PC with the necessary app installed can be used.

[0077] The measuring device 300 (300A, 300B, 300C, etc.) is equipped with the measuring kit of the present invention described above and measures data on the amino acid concentration in a urine sample from a test animal. In one embodiment, the measuring device 300 may include a measuring kit comprising a biosensor 1 and a measuring container 7 as shown in Figures 4 and 5, a control unit 21, a detection unit 22, and a calculation unit 23 as needed. In one embodiment, data of a current value reflecting the amino acid concentration in the urine sample, detected by the detection unit 22 of the measuring device 300, is sent to the server 100 via the internet 50, and the server 100 calculates the amino acid concentration in the urine sample from the test animal from the current value. In another embodiment, the amino acid concentration in the urine sample is calculated by the calculation unit 23 of the measuring device 300, and the calculated amino acid concentration data is sent to the server 100 via the internet 50.

[0078] In a preferred embodiment, the measuring device 300 acquires data on the timing (e.g., measurement date and time) of the measurement of data on the amino acid concentration in the urine sample, and sends the measurement timing data along with the data on the amino acid concentration to the server 100.

[0079] The user terminal 200 and the measuring device 300 are equipped with a communication unit for wired or wireless communication, and data is transmitted and received between the user terminal 200 or the measuring device 300 and the server 100 via this communication unit. The measuring device 300 may be directly connected to the server 100 via the internet 50, as shown in Figure 6, or the measuring device 300 may be connected to the user terminal 200 and connected to the internet 50 via the user terminal 200.

[0080] [Example of operation of the amino acid-related information provision service system]

[0081] Figure 7 illustrates an example of the operation of the server 100, user terminal 200, and measurement device 300 in the service system of the present invention. As a prerequisite for the processing in this example, each user is assumed to possess a user terminal 200 and a measurement device 300 for the test animal. The measurement device 300 is, for example, loaned or transferred by the operator of an amino acid-related information provision service. Each user terminal and measurement device, or the user and test animal using them, are registered and managed on the server 100 (in this example, the identification information of the measurement device is hereinafter referred to as the "sensor ID").

[0082] The user collects urine from a test animal, measures the amino acid concentration in the urine sample using the measuring device 300 (S31), and transmits the measured amino acid concentration data, along with the measurement timing data, to the server 100 (S32). The server 100 receives the amino acid concentration data associated with the measurement timing and sensor ID (S11) and stores this information (S12).

[0083] Next, the server 100 determines whether multiple amino acid concentration data sets associated with the same sensor ID and different measurement timings are stored (S13). If multiple amino acid concentration data sets associated with different measurement timings are stored (Yes in S13), the server 100 generates amino acid-related information, including renal function level information that shows the degree of renal function of the test animal over time (S14).

[0084] On the other hand, if multiple amino acid concentration data associated with different measurement timings are not stored (No in S13), the server 100 generates amino acid-related information, including information on the degree of renal function, which shows the correspondence between the degree of renal function of the test animal and a single measurement timing, similar to S14 (S15).

[0085] Next, the server 100 transmits the created amino acid-related information to the user terminal 200 (S16). The user terminal 200 receives the amino acid-related information (S21) and displays the amino acid-related information (S22).

[0086] As described above, in the amino acid-related information provision service system of the present invention, in addition to being able to accurately measure urinary amino acid concentration using the measuring device 300, the server 100 can create and provide the user with the aforementioned information on the degree of renal function based on the amino acid concentration information accumulated in the server. This makes it possible for users without experimental equipment or testing technology to easily obtain information on urinary amino acid concentration and renal function of test animals.

[0087] (4. Method for Measuring the Substance to be Measured) Next, a method for measuring the substance to be measured in a solution to be measured using the measurement kit of the present invention (hereinafter also referred to as "the measurement method of the present invention") will be described.

[0088] The measurement method of the present invention includes the following: supplying a solution to be measured to a measuring container of the measurement system of the present invention, and dissolving a compound having a pKa of 8 or more and less than 12 in the solution to be measured, wherein the concentration of the compound in the solution to be measured after the compound has been dissolved exceeds 0.05 M; bringing the electrodes of the biosensor of the measurement system into contact with the solution to be measured after the compound has been dissolved; applying a constant voltage to the biosensor with the control unit of the measurement system; detecting a current value obtained from the biosensor with the detection unit of the measurement system; and calculating the concentration of the substance to be measured in the solution to be measured with the calculation unit of the measurement system from the detected current value.

[0089] As an exemplary embodiment of the measurement method of the present invention, a method for measuring the concentration of a substance to be measured in a solution to be measured using the measurement system shown in Figure 5 will be described. This method includes the following steps A to E. Step A: Supply the solution to be measured to the measurement container 7 and dissolve the compound in the measurement container 7 in the solution to be measured, the compound having a pKa of 8 or more and less than 12; Step B: Contact the electrode of the biosensor 1 of the measurement system with the solution in the measurement container 7 in which the compound has been dissolved; Step C: Apply a constant voltage to the biosensor 1 with the control unit 21; Step D: Detect the current value obtained from the biosensor 1 with the detection unit 22; Step E: Calculate the concentration of the substance to be measured with the calculation unit 23 from the detected current value.

[0090] In step A above, the compound in the measuring container 7 dissolves in the solution to be measured, and a solution containing the compound is prepared. In step B above, the solution containing the compound prepared in the measuring container 7 comes into contact with the enzyme electrode 2 (reagent layer 2b), counter electrode 3, and reference electrode 4 of the biosensor 1.

[0091] Steps C to D described above are steps for detecting an electrical signal using chronoamperometry (CA) measurement. When the enzyme electrode 2 and the counter electrode 3 are electrically connected and a predetermined voltage is applied between the enzyme electrode 2 and the counter electrode 3, the value of the steady-state current flowing between the enzyme electrode 2 and the counter electrode 3 is detected. In this specification, a steady-state current refers to a current whose magnitude and direction do not change over time and remain constant.

[0092] In step E, the absolute value of the concentration of the substance to be measured corresponding to the current value is calculated from the current value detected in step D, for example, based on a linear function of the concentration of the substance to be measured and the current value that is pre-stored in the measuring device.

[0093] The measurement method of the present invention allows for the detection of kidney disease in a test animal by measuring the amino acid concentration in a urine sample collected from the test animal. For example, in cats, it is known that kidney disease is suspected when the total concentration of D-amino acids in the urine is approximately 400 μM or less. The measurement method of the present invention enables highly accurate concentration measurement of amino acids in the solution being measured, even in the low concentration range (1000 μM or less), and can therefore be used for a simple diagnosis of kidney disease in cats.

[0094] Therefore, an example of the application of the measurement method of the present invention is a method for examining renal dysfunction in test animals. In this examination method, a urine sample collected from the test animal is used as the solution to be measured. This examination method includes measuring the amino acid concentration in the urine sample using the measurement method of the present invention.

[0095] As one embodiment, a method for testing for renal dysfunction in cats using the measurement system shown in Figure 5 will be described. Here, cat urine can be used as the urine sample. The method includes the following steps A to F. Step A: A urine sample is supplied to the measurement container 7, and a compound in the measurement container 7 having a pKa of 8 or more and less than 12 is dissolved in the urine sample; Step B: The electrodes of the biosensor 1 of the measurement system are brought into contact with the urine sample in the measurement container 7 in which the compound has been dissolved; Step C: A constant voltage is applied to the biosensor 1 by the control unit 21; Step D: The current value obtained from the biosensor 1 is detected by the detection unit 22; Step E: The amino acid concentration in the urine sample is calculated by the calculation unit 23 from the detected current value; Step F: The presence or absence of renal dysfunction in the cat is tested based on the calculated amino acid concentration in the urine sample. The specific processes of steps A to E above are the same as the method for measuring the concentration of the substance to be measured in the solution to be measured described above.

[0096] As exemplary embodiments of the present invention, the following substances, manufacturing methods, uses, or methods are further disclosed herein. However, the present invention is not limited to these embodiments.

[0097] [1] A measurement kit comprising a biosensor equipped with an enzyme electrode and a measuring container for holding a solution to be measured, wherein the enzyme electrode comprises a conductive layer and a reagent layer, the reagent layer comprises an enzyme, the reagent layer is immobilized on the conductive layer, the measuring container contains a compound whose pKa at 25°C, calculated by pH titration, is 8 or more and less than 12, and when the compound is dissolved in the solution to be measured placed in the measuring container, the concentration of the compound in the solution to be measured exceeds 0.05 M. [2] Preferably, the enzyme electrode contains a mediator, more preferably the conductive layer contains a mediator, the mediator is preferably a redox substance, more preferably one or more selected from the group consisting of Prussian blue, ferrocene and its derivatives, osmium complex and its derivatives, ruthenium complex, quinones, dichloroindophenol, tetrathiafulvalene and its derivatives, and tetracyanoquinodimethane, and even more preferably Prussian blue, the measurement kit according to [1]. [3] Preferably, the measurement kit according to [2], a mediator-containing conductive layer is formed so as to cover a part of the surface of the conductive layer, and the reagent layer is immobilized thereon. [4] Preferably, the enzyme electrode contains the mediator, and the mediator content in the enzyme electrode is preferably 0.01% by mass or more, more preferably 0.05% by mass or more, even more preferably 0.10% by mass or more, and preferably 10% by mass or less, more preferably 7.5% by mass or less, and even more preferably 5.0% by mass or less, when the total amount of conductive material and mediator contained in the portion of the enzyme electrode containing the mediator is 100% by mass, and preferably 10% by mass or less, more preferably 7.5% by mass or less, and even more preferably 5.0% by mass or less, and / or the mediator content in the reagent layer is preferably 0.1 μg / mm³ 2 More preferably, 0.01 μg / mm 2The following, and more preferably, the reagent layer does not contain the mediator, is the measurement kit according to [2] or [3]. [5] Preferably, the reagent layer contains a polymeric enzyme immobilizer, and the polymeric enzyme immobilizer is preferably a hydrogel, a cured polymer, or a crosslinked polymer, more preferably a cured polymer, and even more preferably a photosensitive polymer, is the measurement kit according to any one of [1] to [4]. [6] The content of the polymeric enzyme immobilizer in the reagent layer is preferably 0.1 μg / mm³. 2 More preferably 0.2 μg / mm 2 More preferably 0.5 μg / mm 2 The above is true, and preferably 50 μg / mm². 2 More preferably, 40 μg / mm² 2 More preferably, 30 μg / mm² 2The measurement kit according to [5], which is as follows: [7] The measurement kit according to [5] or [6], wherein the mass ratio of the enzyme to the polymeric enzyme immobilizer in the reagent layer (enzyme / polymeric enzyme immobilizer) is preferably 0.01 or more, more preferably 0.05 or more, even more preferably 0.10 or more, and preferably 10 or less, more preferably 7.5 or less, and even more preferably 5 or less. [8] A measurement kit according to any one of [1] to [7], preferably used to measure the concentration of a substance to be measured in the solution to be measured, wherein the substance to be measured is preferably glucose, lactic acid, fructose, urea, uric acid, amino acids, bilirubin, cholesterol, alcohol, creatinine, or ascorbic acid, more preferably a D-amino acid, wherein the amino acid is preferably a D-amino acid, and more preferably at least one selected from the group consisting of D-alanine, D-serine, D-arginine, D-lysine, D-asparagine, D-histidine, D-ornithine, D-glutamine, D-threonine, D-tyrosine, D-valine, D-phenylalanine, D-methionine, D-glutamic acid, D-aspartic acid, D-leucine, D-tryptophan, D-cysteine, D-isoleucine, and D-proline. [9] The measurement kit according to any one of [1] to [8], wherein the enzyme is preferably glucose oxidase (GOD), glucose dehydrogenase (GDH), lactate oxidase, lactate dehydrogenase, fructose dehydrogenase, invertase, amylase, urease, uricase, amino acid oxidase, bilirubin oxidase, cholesterol oxidase, alcohol oxidase, alcohol dehydrogenase, or creatininase, and more preferably amino acid oxidase.

[10] The enzyme content in the reagent layer is preferably 0.1 μg / mm³. 2 More preferably 0.2 μg / mm 2 More preferably 0.5 μg / mm 2 The above is required, and preferably 30 μg / mm². 2 More preferably, 25 μg / mm² 2 More preferably, 15 μg / mm²2 The following is a measurement kit according to any one of [1] to [9].

[11] The measurement kit according to any one of [1] to

[10] , wherein the compound having a pKa of 8 or more and less than 12 is preferably at least one selected from the group consisting of compounds having an amine moiety, boric acid, and boronic acid, more preferably a compound having an amine moiety, even more preferably at least one selected from the group consisting of trishydroxymethylaminomethane, 2-cyclohexylaminoethanesulfonic acid, N-tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid, N,N-di(2-hydroxyethyl)glycine, and boric acid, and even more preferably trishydroxymethylaminomethane.

[12] The measurement kit according to any one of [1] to

[11] , wherein the amount of the compound having a pKa of 8 or more and less than 12 in the solution to be measured is preferably 0.1 M or more, and more preferably 0.1 to 2.0 M.

[13] The measurement kit according to any one of [1] to

[12] , wherein the measuring container preferably further comprises a pH adjusting agent, more preferably a buffer solution prepared by mixing a compound having a pKa of 8 or more and less than 12 with a pH adjusting agent, and the buffer solution is preferably an aqueous solution of Tris hydrochloride, an aqueous solution of CHES ammonia salt, an aqueous solution of TAPS ammonia salt, or an aqueous solution of ammonium borate.

[14] The measurement kit according to any one of [1] to

[13] , wherein the solution to be measured is preferably a urine sample collected from a test animal.

[15] The measurement kit according to

[14] , wherein the test animal is preferably a mammal, more preferably a non-human animal, and even more preferably a feline.

[16] The measurement kit according to any one of [1] to

[15] , wherein the material of the conductive layer is preferably at least one selected from the group consisting of gold, palladium, platinum, rhodium, indium, iridium, and conductive carbon material.

[17] The area of ​​the reagent layer is preferably 0.1 mm 2 Above 1000mm 2A measurement kit according to any one of [1] to

[16] , wherein the thickness of the reagent layer is preferably 10 nm or more and 100 μm or less.

[18] Preferably, a measurement kit according to any one of [1] to

[17] , wherein the biosensor is fixed in advance inside the measurement container, or the biosensor is arranged inside the measurement container such that the electrode is exposed.

[19] Preferably, a measurement kit according to any one of [1] to

[17] , comprising one biosensor and a plurality of measurement containers.

[20] The measurement kit according to any one of [1] to

[19] , wherein the biosensor preferably further comprises a reference electrode, more preferably further comprises a counter electrode and a reference electrode, the distance between the enzyme electrode and the counter electrode and the reference electrode is preferably 0.1 mm or more and 100 mm or less, the thickness of the enzyme electrode, the counter electrode and the reference electrode is preferably 10 nm or more and 100 μm or less, and the width of the counter electrode and the reference electrode is preferably 0.1 to 100 mm.

[21] The measurement kit according to any one of [1] to

[20] , wherein the conductive layer and the reagent layer are arranged on a substrate.

[22] The measurement kit according to

[21] , wherein the substrate is made of an insulating material. A measurement system for a substance to be measured, comprising: a measurement kit comprising a biosensor and a measuring container as described in any one of items

[23] [1] to

[22] ; a control unit for controlling the application of voltage to the biosensor; a detection unit for detecting a current value obtained by applying voltage to the biosensor; a calculation unit for calculating the concentration of the substance to be measured in the solution to be measured from the current value; and an output unit for outputting the calculated concentration of the substance to be measured.

[24] A method for measuring a substance to be measured, comprising: supplying a solution to be measured to a measuring container of the measuring system described in

[23] , dissolving a compound in the solution to be measured whose pKa at 25°C calculated by pH titration is 8 or more and less than 12, wherein the concentration of the compound in the solution to be measured in which the compound is dissolved exceeds 0.05 M; bringing the electrode of the biosensor of the measuring system into contact with the solution to be measured in which the compound is dissolved; applying a constant voltage to the biosensor with the control unit of the measuring system; detecting a current value obtained from the biosensor with the detection unit of the measuring system; and calculating the concentration of the substance to be measured in the solution to be measured with the calculation unit of the measuring system from the detected current value.

[25] An amino acid-related information provision service system that provides amino acid-related information concerning a test animal, the system comprising: a server; a user terminal; and a measuring device equipped with a measuring kit described in any one of items [1] to

[22] , wherein the user terminal and the measuring device are each identified, the user terminal is associated with the measuring device, the measuring device measures data on the amino acid concentration of a urine sample taken from a test animal, and transmits the measured data along with the timing data of the measurement to the server, the server creates amino acid concentration-related information for the test animal based on the data transmitted from the measuring device, and transmits the information to the user terminal associated with the measuring device, the user terminal outputs the amino acid concentration-related information for the test animal transmitted from the server, and the amino acid-related information for the test animal includes information on the urinary amino acid concentration of the test animal, or information on the renal function of the test animal created based on the urinary amino acid concentration.

[0098] The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these examples.

[0099] Example 1 (1. Fabrication of Biosensor) [Fabrication of Electrode System] As an insulating substrate 5, a 225 μm thick polyimide film (manufactured by AS ONE Corporation) was screen printed with carbon paste (manufactured by SUN CHEMICALS, C2030519P4) through a screen mask and dried at 80°C for 10 minutes to form an electrode pattern for the enzyme electrode 2, counter electrode 3, and reference electrode 4 as shown in Figure 8A. Prussian blue-containing carbon paste (manufactured by SUN CHEMICALS, C2070424P2) was screen printed through a screen mask so as to overlap the circular part of the electrode in the center of the electrode pattern and dried at 80°C for 10 minutes to form a mediator-containing conductive layer 2a' on a part of the conductive layer 2a (Figure 8B). The electrode on the left side of the electrode pattern was used as the counter electrode 3. Reference electrode 4 was fabricated by screen printing silver / silver chloride paste (SUN CHEMICALS, C2130809D5) through a screen mask so that it overlapped the right-hand end of the electrode pattern, and then drying it at 80°C for 10 minutes. In the above procedure, the carbon paste, Prussian blue-containing carbon paste, and silver / silver chloride paste were each applied by screen printing to a thickness of 8 μm after drying.

[0100] [Enzyme Modification] A mixed solution was prepared by mixing a PBS solution (phosphate-buffered saline, pH 7.2, Life Technology) containing 2% by mass of enzyme (D-amino acid oxidase, manufactured by SIGMA-Aldrich) with a 6% by mass solution of photosensitive polymer (Biosurfine-AWP-MRH, manufactured by Toyo Gosei Kogyo Co., Ltd.) in a volume ratio of 1:2. 1.2 μL of this mixed solution was dropped onto the mediator-containing conductive layer 2a', dried at 25°C for 20 hours, and then cured by UV irradiation for 1 minute to immobilize the reagent layer 2b on the conductive layer 2a', thereby fabricating the enzyme electrode 2 (Figure 8B). The area of ​​the reagent layer 2b was 3.14 mm². 2 The thickness is 5 μm, and the D-amino acid oxidase content in reagent layer 2b is 2.55 μg / mm³. 2 The content of the cured product of Biosurfine-AWP-MRH is 15.3 μg / mm³. 2 That was the case.

[0101] (2. Preparation of a measuring container containing the compound) Tris hydrochloride aqueous solution (pH 8.0) was obtained by dropping 6M hydrochloric acid into a 0.4 g / mL aqueous solution of trishydroxymethylaminomethane (Tris) (manufactured by Fujifilm Wako Pure Chemical Industries). A measuring container containing Tris solidified at the bottom was prepared by dropping 160 μL of this Tris hydrochloride aqueous solution into a 1.5 mL microtube and drying under reduced pressure at 25°C for 20 hours.

[0102] (3. Current Measurement) A 0.2 mM D-alanine aqueous solution was used as the solution to be measured. 0.5 mL of the solution to be measured was filled into the measurement container, and Tris in the container was dissolved in the solution to be measured. The Tris concentration in the solution to be measured was 1.06 M. As shown in Figure 4, the enzyme electrode 2, counter electrode 3, and reference electrode 4 of the biosensor were connected to a potentiostat, and the biosensor was immersed in the solution to be measured in the measurement container. Chronoamperometry (CA) measurement was performed by applying a constant potential of -0.1 V (against the reference electrode 4) to the enzyme electrode 2 using the potentiostat. The current value after 150 seconds of voltage application was -0.22 μA, and the current value after 300 seconds was -0.24 μA. The difference between the current value at 300 seconds and the current value at 150 seconds was 0.02 μA, indicating that a steady current was obtained at 150 seconds.

[0103] Example 2 A biosensor and measurement container were prepared using the same procedure as in Example 1, except that the amount of Tris hydrochloride aqueous solution dropped into the microtube was 25 μL. 100 μL of 0.2 mM D-alanine aqueous solution was filled into the measurement container and dissolved. The Tris concentration in the solution was 0.83 M. Next, CA measurement was performed using the same procedure as in Example 1. The current value after 150 seconds of voltage application was -0.26 μA, and the current value after 300 seconds was -0.25 μA. The difference between the current value at 300 seconds and the current value at 150 seconds was 0.01 μA, indicating that a steady current was obtained at 150 seconds.

[0104] Example 3 A biosensor and measurement container were prepared using the same procedure as in Example 1, except that the amount of Tris hydrochloride aqueous solution dropped into the microtube was 7.5 μL. 100 μL of 0.2 mM D-alanine aqueous solution was filled into the measurement container and dissolved. The Tris concentration in the solution was 0.25 M. Next, CA measurement was performed using the same procedure as in Example 1. The current value after 150 seconds of voltage application was -0.27 μA, and the current value after 300 seconds was -0.23 μA. The difference between the current value at 300 seconds and the current value at 150 seconds was 0.04 μA, indicating that a steady current was obtained at 150 seconds.

[0105] Example 4 A biosensor was prepared using the same procedure as in Example 1. A 5M aqueous ammonia solution of 2-cyclohexylaminoethanesulfonic acid (CHES) (manufactured by Fujifilm Wako Pure Chemical Industries) was added dropwise to a 0.052 g / mL aqueous solution of 2-cyclohexylaminoethanesulfonic acid (CHES) to obtain an aqueous CHES ammonia solution (pH 9.0). 100 μL of this aqueous CHES ammonia solution was added dropwise to a 1.5 mL microtube, and the container was dried under reduced pressure at 25°C for 20 hours to prepare a measuring container containing solidified CHES at the bottom.

[0106] 100 μL of 0.2 mM D-alanine aqueous solution was filled into the measuring container and dissolved. The CHES concentration in the solution was 0.25 M. Next, CA measurement was performed using the same procedure as in Example 1. The current value after 150 seconds of voltage application was -0.44 μA, and the current value after 300 seconds was -0.42 μA. The difference between the current value at 300 seconds and the current value at 150 seconds was 0.02 μA, indicating that a steady current was obtained at 150 seconds.

[0107] Example 5 A biosensor was prepared using the same procedure as in Example 1. An aqueous solution of TAPS ammonia salt (pH 8.0) was obtained by adding 5 M aqueous ammonia water dropwise to a 0.061 g / mL aqueous solution of tris(hydroxymethyl)methylaminopropanesulfonic acid (TAPS) (manufactured by Fujifilm Wako Pure Chemical Industries). 100 μL of this aqueous solution of TAPS ammonia salt was added dropwise to a 1.5 mL microtube, and the container was dried under reduced pressure at 25°C for 20 hours to prepare a measuring container containing solidified TAPS at the bottom.

[0108] 100 μL of 0.2 mM D-alanine aqueous solution was filled into the measuring container and dissolved. The TAPS concentration in the solution was 0.25 M. Next, CA measurement was performed using the same procedure as in Example 1. The current value after 150 seconds of voltage application was -0.35 μA, and the current value after 300 seconds was -0.30 μA. The difference between the current value at 300 seconds and the current value at 150 seconds was 0.05 μA, indicating that a steady current was obtained at 150 seconds.

[0109] Example 6 A biosensor was prepared using the same procedure as in Example 1. An aqueous solution of ammonium borate (pH 9.0) was obtained by dropping 5 M ammonia water into a 0.016 g / mL aqueous solution of boric acid (manufactured by Fujifilm Wako Pure Chemical Industries). 100 μL of this aqueous solution of ammonium borate was dropped into a 1.5 mL microtube, and the container was dried under reduced pressure at 25°C for 20 hours to prepare a measuring container containing solidified boric acid at the bottom.

[0110] 100 μL of 0.2 mM D-alanine aqueous solution was filled into the measuring container and dissolved. The boric acid concentration in the solution was 0.25 M. Next, CA measurement was performed using the same procedure as in Example 1. The current value after 150 seconds of voltage application was -0.28 μA, and the current value after 300 seconds was -0.26 μA. The difference between the current value at 300 seconds and the current value at 150 seconds was 0.02 μA, indicating that a steady current was obtained at 150 seconds.

[0111] Comparative Example 1 A biosensor and measurement container were prepared using the same procedure as in Example 1, except that the amount of Tris hydrochloride aqueous solution dropped into the microtube was 1.5 μL. 100 μL of 0.2 mM D-alanine aqueous solution was filled into the measurement container and dissolved. The Tris concentration in the solution was 0.05 M. Next, CA measurement was performed using the same procedure as in Example 1. The current value after 150 seconds of voltage application was -0.33 μA, and the current value after 300 seconds was -0.11 μA. The difference between the current value at 300 seconds and the current value at 150 seconds was 0.22 μA, indicating that a steady current had not yet been reached at 150 seconds.

[0112] Comparative Example 2 A biosensor was prepared using the same procedure as in Example 1. A measuring container containing phosphoric acid was prepared by dropping 400 μL of 0.1 M phosphate buffer (manufactured by Fujifilm Wako Pure Chemical Industries, pH 8.0) into a 1.5 mL microtube and drying under reduced pressure at 25°C for 20 hours. 100 μL of 0.2 mM D-alanine aqueous solution was packed into the measuring container and dissolved. The phosphoric acid concentration in the solution was 0.1 M. Next, CA measurement was performed using the same procedure as in Example 1. The current value after 150 seconds of voltage application was -0.54 μA, and the current value after 300 seconds was -0.21 μA. The difference between the current value at 300 seconds and the current value at 150 seconds was 0.33 μA, indicating that a steady current had not yet been reached at 150 seconds.

[0113] The pKa of Tris, Ches, Taps, and phosphoric acid, which were included in the measurement containers in pKa Measurement Examples 1-6 and Comparative Examples 1-2, was measured by pH titration. A potentiometric automatic titrator AT-710 (manufactured by Kyoto Electronics Manufacturing Co., Ltd.) was used for pH titration. The compounds were dissolved in ultrapure water to a concentration of 0.1 mol / L. 10 mL of the resulting solution was placed in a 50 mL PP disposable cup (manufactured by Sanplatec Co., Ltd.), a micro stirrer bar φ2 × 7 mm (manufactured by AS ONE Corporation) was added, and the stirrer bar was rotated at 500 rpm. After adjusting the pH of the solution to 3 or less by adding hydrochloric acid, pH titration was started. 1.5 mL of 1 mol / L hydrochloric acid was added to the Tris solution. 5 mL of 0.1 mol / L hydrochloric acid was added to the Ches, Taps, and phosphoric acid solutions. In the pH titration, 0.1 mol / L sodium hydroxide was added dropwise so that each drop was between 0.05 and 0.2 mL. A graph representing the rate of pH change of the solution was created from the following x and y values: x: pH of the solution (3 ≤ x ≤ 12) y: rate of pH change (pH / mL) obtained by differentiating the pH before and after titration with respect to the volume added. The pKa of the compound was calculated as the x value at which the absolute value of y decreased to 0.3 or less on the graph smoothed using the three-point moving average method, and the first minimum was reached after that. As an example of the graph and pKa calculation, Figures 10-14 show the rate of pH change of Tris. The arrows in the figures indicate the first minimum value, and the x value at that time (= 8.6) was adopted as the pKa of Tris. The pKa of other compounds was calculated using the same procedure.

[0114] Table 1 shows the results of the pKa and current measurements of the compounds in the measurement solutions for Examples 1 to 6 and Comparative Examples 1 to 2.

[0115]

[0116] Test Example 1 The amino acid concentration was measured using the biosensor and Tris-containing measuring container of Example 1. 0.5 mL of the solution to be measured containing D-alanine was filled into the measuring container, and the Tris inside the container was dissolved in the solution to be measured. As shown in Figure 4, the enzyme electrode 2, counter electrode 3, and reference electrode 4 of the biosensor were connected to a potentiostat, and the biosensor was immersed in the solution to be measured in the measuring container. CA measurement was performed by applying a constant potential of -0.1 V (against the reference electrode 4) to the enzyme electrode 2 using the potentiostat, and the current value was measured 150 seconds after the voltage was applied. The current values ​​measured from the solutions to be measured with D-alanine concentrations of 0 mM, 0.2 mM, 0.5 mM, and 1.0 mM were -0.09 μA, -0.24 μA, -0.38 μA, and -0.58 μA, respectively. As shown in Figure 9, the steady-state current value decreased as the D-alanine concentration in the solution being measured increased, indicating a linear relationship between D-alanine concentration and steady-state current value. This demonstrates that the D-alanine concentration in the solution being measured can be quantified with a short waiting time by using the biosensor and Tris-containing measuring container of Example 1.

[0117] 1 Biosensor 2 Enzyme electrode 2a Conductive layer 2a' Mediator-containing conductive layer 2b Reagent layer 3 Counter electrode 4 Reference electrode 5 Substrate 6 Insulating layer 6a Opening 7 Measurement container 8 Compound 10 Potentiostat 11 Solution to be measured 20 Measurement device 21 Control unit 22 Detection unit 23 Calculation unit 24 Output unit 25 Display unit 26 Storage unit 50 Internet 100 Server 200 User terminal 300 Measurement device

Claims

1. A measurement kit comprising a biosensor equipped with an enzyme electrode and a measuring container for holding a solution to be measured, wherein the enzyme electrode comprises a conductive layer and a reagent layer, the reagent layer comprises an enzyme, the reagent layer is immobilized on the conductive layer, the measuring container contains a compound whose pKa at 25°C, calculated by pH titration, is 8 or more and less than 12, and when the compound is dissolved in the solution to be measured placed in the measuring container, the concentration of the compound in the solution to be measured exceeds 0.05 M.

2. The measurement kit according to claim 1, wherein the compound having a pKa of 8 or more and less than 12 is at least one selected from the group consisting of compounds having an amine moiety, boric acid, and boronic acid.

3. The measurement kit according to claim 1, wherein the compound having a pKa of 8 or more and less than 12 is a compound having an amine moiety.

4. The measurement kit according to claim 1, wherein the compound having a pKa of 8 or more and less than 12 is at least one selected from the group consisting of trishydroxymethylaminomethane, 2-cyclohexylaminoethanesulfonic acid, N-tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid, N,N-di(2-hydroxyethyl)glycine, and boric acid.

5. The measurement kit according to claim 1, wherein the compound having a pKa of 8 or more and less than 12 is trishydroxymethylaminomethane.

6. The measurement kit according to claim 1, wherein the conductive layer includes a mediator.

7. The measurement kit according to claim 6, wherein the mediator is Prussian blue.

8. The measurement kit according to claim 6, wherein the mediator content in the conductive layer is 0.01% by mass or more and 10% by mass or less.

9. The mediator content in the reagent layer is 0.1 μg / mm³. 2 The measurement kit according to claim 6, which is as follows:

10. The measurement kit according to claim 1, wherein the enzyme is an amino acid oxidase.

11. The enzyme content in the reagent layer is 0.1 μg / mm³. 2 30μg / mm or more 2 The measurement kit according to claim 1, which is as follows:

12. The measurement kit according to claim 1, wherein the reagent layer contains a polymeric enzyme immobilizer.

13. The measurement kit according to claim 12, wherein the polymeric enzyme immobilizer is a photosensitive polymer.

14. The measurement kit according to claim 1, wherein the biosensor further comprises a reference electrode.

15. The measurement kit according to claim 14, further comprising a counter electrode on the substrate.

16. The measurement kit according to claim 1, wherein the conductive layer and the reagent layer are arranged on a substrate.

17. The measurement kit according to claim 16, wherein the substrate is made of an insulating material.

18. A measurement system for a substance to be measured, comprising: a measurement kit according to any one of claims 1 to 17, comprising: a control unit for controlling the application of voltage to the biosensor; a detection unit for detecting a current value obtained by applying voltage to the biosensor; a calculation unit for calculating the concentration of a substance to be measured in a solution to be measured from the current value; and an output unit for outputting the calculated concentration of the substance to be measured.

19. The measurement system according to claim 18, wherein the substance to be measured is an amino acid.

20. A method for measuring a substance to be measured, comprising: supplying a solution to be measured to a measuring container of the measuring system according to claim 18; dissolving a compound in the solution to be measured whose pKa at 25°C, calculated by pH titration, is 8 or more and less than 12, wherein the concentration of the compound in the solution to be measured after the compound has been dissolved exceeds 0.05 M; contacting the electrode of the biosensor of the measuring system with the solution to be measured after the compound has been dissolved; applying a constant voltage to the biosensor with the control unit of the measuring system; detecting a current value obtained from the biosensor with the detection unit of the measuring system; and calculating the concentration of the substance to be measured in the solution to be measured with the calculation unit of the measuring system from the detected current value.

21. The method according to claim 20, wherein the substance to be measured is an amino acid.

22. An amino acid-related information provision service system that provides amino acid-related information concerning a test animal, the system comprising: a server; a user terminal; and a measuring device equipped with a measuring kit according to any one of claims 1 to 17, wherein the user terminal and the measuring device are each identified, the user terminal is associated with the measuring device, the measuring device measures data on the amino acid concentration of a urine sample taken from a test animal, and transmits the measured data along with the timing data of the measurement to the server, the server creates amino acid concentration-related information for the test animal based on the data transmitted from the measuring device, and transmits the information to the user terminal associated with the measuring device, the user terminal outputs the amino acid concentration-related information for the test animal transmitted from the server, and the amino acid-related information for the test animal includes information on the urinary amino acid concentration of the test animal, or information on the renal function of the test animal created based on the urinary amino acid concentration.